Integrating homeopathic care into a comprehensive cancer center
Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
This project will try offering homeopathic consultations to adult cancer patients at Rambam to see if patients accept and can use this approach as part of supportive care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rambam Health Care Campus Academic / other |
| Locations | 1 site (Haifa) |
| Trial ID | NCT05833165 on ClinicalTrials.gov |
What this trial studies
This is an observational feasibility project at Rambam Health Campus that offers homeopathic consultations within the existing complementary and integrative oncology service. Adult oncology patients who meet eligibility criteria will be invited to a detailed homeopathic interview and follow-up, and investigators will record uptake, reasons for choosing the service, completion of visits, and any logistical barriers. The study will collect basic patient-reported information about experience and tolerability but does not test clinical efficacy. Results will focus on acceptability, integration challenges, and practical implementation metrics to inform future work.
Who should consider this trial
Good fit: Adults (18+) treated in the Division of Oncology at Rambam who read and understand Hebrew, have ECOG performance status 0–2, and consent to participate are ideal candidates.
Not a fit: Patients with active psychosis, severe cognitive impairment, frailty or ECOG >2, or other unstable acute medical conditions are unlikely to benefit or be eligible to participate.
Why it matters
Potential benefit: If successful, it could provide an additional supportive care option that some patients find helpful for well‑being and symptom coping.
How similar studies have performed: While integrative oncology services commonly include homeopathy in some countries, high‑quality evidence of clinical benefit in cancer patients is limited, so feasibility work like this remains relatively novel in the Israeli comprehensive cancer center setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • 18 years of age or older * Ability to read, write, and understand the Hebrew language * Patients treated at the Division of Oncology in Rambam Health Campus. * Performance status of ECOG 0-2. * Consent to participate in the study. Exclusion Criteria: * • Inability to understand the intent of the study and follow the instructions * Diagnosis of active psychosis, altered mental state or severe cognitive impairment confirmed by the patient's attending physician. * Frailty, ECOG worse than 2, or other unstable medical conditions as confirmed by the patient's attending physician including acute illness, fever, unclear rash or medical conditions that would preclude participation in an interview session lasting 15-30 minutes
Where this trial is running
Haifa
- Rambam Medical Center — Haifa, Israel (Recruiting)
Study contacts
- Study coordinator: Moshe Frenkel, MD
- Email: frenkelm@netvision.net.il
- Phone: 972523311255
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.